Adverse events: nausea · heavy menstrual bleeding
Combined oral contraceptive pill may leads to higher adverse events: nausea compared with contraceptive vaginal ring (low certainty).
1 finding from 1 review
Improvement in MBL (participant assessment) · heavy menstrual bleeding
Combined oral contraceptive pill probably leads to higher improvement in MBL (participant assessment) compared with placebo (moderate certainty).
1 finding from 1 review
Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ treatment emergent · heavy menstrual bleeding
Combined oral contraceptive pill probably leads to higher adverse events ‐ Any adverse events (treatment‐emergent) compared with placebo (moderate certainty).
1 finding from 1 review
Menstrual blood loss: mean loss · heavy menstrual bleeding
1 finding from 1 review
Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success rate · heavy menstrual bleeding
Combined oral contraceptive pill may leads to lower treatment success (PBAC < 100 at end of treatment or no requirement… compared with levonorgestrel‐releasing intrauterine system (low certainty).
1 finding from 1 review
Satisfaction with treatment · heavy menstrual bleeding
It is very uncertain whether combined oral contraceptive pill changes satisfaction with treatment compared with levonorgestrel‐releasing intrauterine system (very low certainty).
1 finding from 1 review
Uterine fibroid‐related symptoms (duration of uterine bleeding, measured at 12 weeks; lower = better) · women with uterine fibroids
1 finding from 1 review
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (hot flushes) · women with uterine fibroids
1 finding from 1 review
Clinical pregnancy per woman ‐ oral route · women trying to conceive by intrauterine insemination
It is very uncertain whether progesterone changes clinical pregnancy per woman ‐ oral route compared with no treatment or placebo (route of progesterone administration) (very low certainty).
1 finding from 1 review
Metabolic: oral glucose tolerance test (OGTT) glucose (mmol/L/minute) · women with polycystic ovary syndrome
1 finding from 1 review
Pain score during procedure: oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Pain score within 30 min of procedure oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Pain score more than 30 min after procedure oral opioid · women undergoing outpatient hysteroscopy
1 finding from 1 review
Miscarriage · ovulation induction in polycystic ovarian syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Live birth or ongoing pregnancy IM vs oral · subfertile women
It is very uncertain whether the intervention changes live birth or ongoing pregnancy IM vs oral (very low certainty).
1 finding from 1 review